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The inner nuclear membrane (INM) is continuous with
the endoplasmic reticulum (ER) but harbors a distinc-
tive proteome essential for nuclear functions. In
yeast, the Asi1/Asi2/Asi3 ubiquitin ligase complex
safeguards the INM proteome through the clearance
of mislocalized ER membrane proteins. How the Asi
complex selectively targets mislocalized proteins
and coordinates its activity with other ER functions,
such as protein biogenesis, is unclear. Here, we un-
cover a link between INM proteome identity and
membrane protein complex assembly in the remain-
ing ER.We show that lone proteins and complex sub-
units failing to assemble in the ER access the INM for
Asi-mediated degradation. Substrates are recog-
nized by direct binding of Asi2 to their transmem-
brane domains for subsequent ubiquitination by
Asi1/Asi3 and membrane extraction. Our data sug-
gest a model in which spatial segregation of mem-
brane protein complex assembly and quality control
improves assembly efficiency and reduces the levels
of orphan subunits.
INTRODUCTION
The inner nuclear membrane (INM), which, together with
the outer nuclear membrane, forms the nuclear envelope, is
a specialized domain of the endoplasmic reticulum (ER). In
contrast to bulk ER membranes that face the cytoplasm, the
INM controls chromosome positioning within the nucleus,
thereby influencing numerous processes from gene expression
to DNA replication and repair (Hetzer, 2010; DeMagistris and An-
tonin, 2018). These INM functions require a unique proteome that
is distinct from that of the remaining ER membranes (Ungricht
and Kutay, 2015). Mutations in INM proteins are frequently asso-
ciated with diseases such as muscular dystrophies, progeroid
syndromes, and cancer, underscoring the importance of main-
taining protein homeostasis in this ER domain (Worman and
Schirmer, 2015).108 Molecular Cell 77, 108–119, January 2, 2020 ª 2019 The Author(
This is an open access article under the CC BY license (http://creativeThe INM is continuous with the remaining ER membrane, and
its unique identity requires correct protein targeting. Upon syn-
thesis and membrane insertion in the bulk ER, INM proteins
diffuse in the membrane until they reach the INM, where they
are retained through interactions with nuclear factors such as
chromatin (Boni et al., 2015; Ungricht et al., 2015). Besides
this diffusion-retention model, other mechanisms have been
proposed for the targeting of proteins to the INM (Katta
et al., 2014).
In yeast, the establishment of INM proteome identity is also
achieved through the elimination of mislocalized proteins by
ER-associated degradation (ERAD), a quality control process
that includes multiple branches. Mislocalized proteins are tar-
geted by an INM-specific ERAD branch defined by the Asi ubiq-
uitin ligase complex (Foresti et al., 2014; Khmelinskii et al.,
2014). Other ERAD branches encompass distinct ubiquitin
ligase complexes, the Hrd1 and Doa10 complexes, which
have major roles in the quality control of misfolded proteins in
bulk ER membranes (Mehrtash and Hochstrasser, 2019; Rug-
giano et al., 2014).
The Asi complex is composed of Asi1, Asi2, and Asi3; Asi1
and Asi3 contain RING domains, conferring ubiquitin ligase ac-
tivity, while Asi2 does not have known functional domains.
Mislocalized proteins ubiquitinated by the Asi complex are
subsequently extracted from the INM by the soluble ATPase
Cdc48 (p97 in mammals) in complex with its cofactors Npl4
and Ufd1 and handed to the proteasome for degradation
(Bays et al., 2001; Foresti et al., 2014; Jarosch et al., 2002;
Khmelinskii et al., 2014; Rabinovich et al., 2002; Ye et al.,
2001). How the Asi complex specifically recognizes ‘‘mislocal-
ized’’ proteins at the INM remains unclear. It is also unknown
how the degradation of mislocalized proteins at the INM con-
tributes to protein homeostasis in the bulk ER, as shown by
previous genetic studies (Foresti et al., 2014; Khmelinskii
et al., 2014).
Here, we uncover a link between INM proteome identity and
quality control of the membrane protein complex assembly.
Unassembled subunits of protein complexes constitute a
significant burden to cells, as shown by recent proteomics ex-
periments (McShane et al., 2016). However, quality control pro-
cesses involved in their degradation have remained elusive
(Juszkiewicz and Hegde, 2018). We show that folded unassem-





Figure 1. Orphan Subunits of ER Protein Complexes Are Degraded by the Asi Complex
(A) Scheme of the OST complex. Different shades of blue indicate the three subcomplexes that form OST.
(B) The degradation of the OST complex mutant subunit wbp1-2 was followed after inhibition of protein synthesis by cycloheximide (CHX) in cells with the
indicated genotype upon a 45-min shift to 30C.Wbp1 was detected with a-Wbp1 antibody. Dolichol phosphate mannose synthase (Dpm1) was used as loading
control and detected with a-Dpm1 antibody. The graph (right) shows the quantification of at least three independent experiments; error bars represent the
standard deviation.
(C) The degradation of endogenous Wbp1 in WT and asi1D cells was analyzed as in (B).
(D) The degradation of endogenous Wbp1 in cells with the indicated genotype was analyzed upon a 60-min shift to 37C and samples processed as in (B). In
ost2-ts cells, Wbp1 is hypoglycosylated and runs as a doublet (arrowheads). The graph (right) shows the quantification of at least three independent experiments;
error bars represent the standard deviation.
(E) The degradation of endogenous Wbp1 in cells with the indicated genotype was analyzed as in (D). In stt3-7 cells, Wbp1 is hypoglycosylated and runs as a
doublet (arrowheads). The graph (right) shows the quantification of at least three independent experiments; error bars represent the standard deviation.
(F) The degradation of endogenous Wbp1 was followed after the inhibition of protein synthesis by CHX upon acute depletion of its binding partner Swp1-AID-
FLAG (bottom). Dpm1 was used as loading control and detected with a-Dpm1 antibody. The graph (right) shows the quantification of at least three independent
experiments; error bars represent the standard deviation. Auxin-induced Swp1-AID-FLAG depletion inWT and asi1D cells was confirmed by blotting with a-FLAG
antibody (top). Pgk1 was used as loading control and detected with a-Pgk1 antibody.
(G) Serial dilutions of cells with the indicated genotype were spotted on YPD and incubated for 2 days at 25C and 33C.in bulk ER membranes. Instead, these orphan subunits diffuse
easily to the INM, where they are recognized by the Asi complex.
Using in vivo crosslinking and in vitro reconstitution experiments,
we show that recognition is mediated by the direct binding of
Asi2 to substrate transmembrane domains (TMDs). Asi2 binding
facilitates substrate ubiquitination and subsequent Cdc48-medi-
ated extraction. We propose that restricting the quality control of
unassembled proteins to the INM, a relatively small region of the
ER that is not involved in protein biogenesis, spares subunits
from premature degradation and offers them more time to find
their partners. Thus, spatial segregation of the two processes,
protein assembly (in the bulk ER) and quality control (at the
INM), may facilitate efficient complex assembly.RESULTS
Asi Degrades Unassembled Complex Subunits
We previously showed that degradation of the Asi complex
substrate Nsg1 was strongly accelerated in cells lacking its
binding partner Hmg2 (Foresti et al., 2014). We also showed
that Erg11, a p450 protein family member that noticeably
does not assemble into stable complexes (Debose-Boyd,
2007; Hughes et al., 2007), was constitutively degraded in
an Asi-dependent manner. These observations raise the pos-
sibility that by targeting lone or unassembled subunits, the
Asi complex is involved in the quality control of protein com-
plex assembly.Molecular Cell 77, 108–119, January 2, 2020 109
To test this hypothesis, we analyzed the oligosaccharyl trans-
ferase (OST; Figure 1A) and the glycosylphosphatidylinositol
transamidase (GPI-T; Figure S1A) complexes, which are ER
membrane protein complexes that are required for N-linked pro-
tein glycosylation and protein GPI anchor attachment, respec-
tively (Benghezal et al., 1996; Fraering et al., 2001; te Heesen
et al., 1993; Kelleher and Gilmore, 1994). Both OST and GPI-T
complexes are essential for cell viability, and to conditionally per-
turb their assembly we took advantage of temperature-sensitive
(ts) alleles of Wbp1, an OST subunit, and Gpi8, a GPI-T subunit.
Mutant proteins encoded by ts alleles are commonly degraded
at the restrictive temperature. We tested whether previously
described ts alleles of Wbp1 and Gpi8 would result in unstable
proteins (Ben-Aroya et al., 2008; te Heesen et al., 1993; Li
et al., 2011). While both endogenous Wbp1 and Gpi8 are rela-
tively long-lived proteins, their ts allele-encoded counterparts
Wbp1-2 and Gpi8-ts were quickly degraded. In contrast, both
were strongly stabilized in Asi mutants (Figures 1B, 1C, S1B,
and S1C).
The assembly of the OST complex is well characterized (Kel-
leher and Gilmore, 1994), and its structure was recently solved
(Bai et al., 2018; Wild et al., 2018). Moreover, the stability of
the various subunits and their interdependencies are known (Mu-
eller et al., 2015). Therefore, we considered it a good model to
further study the role of the Asi complex in quality control of
the protein complex assembly. The OST complex is composed
of three subcomplexes (Figure 1A). One of these is formed by
Wbp1, Ost2, and Swp1, with the stability of each subunit de-
pending on the presence of the other two (Mueller et al., 2015).
In cells expressing the ost2-ts allele, we observed rapid degra-
dation of Wbp1. In contrast, the half-life of Wbp1 was extended
in ost2-ts cells lacking Asi components (Figure 1D). Destabiliza-
tion of the OST complex in the ost2-tsmutant was confirmed by
immunoprecipitation experiments in cells expressing a func-
tional tagged version of Ost4, another OST subunit (Figure S1E).
In contrast, destabilization of Stt3, which belongs to a distinct
OST subcomplex (Figure 1A) and does not interfere with the
Wbp1-Swp1-Ost2 assembly (Mueller et al., 2015), did not affect
Wbp1 levels and turnover (Figure 1E).
Furthermore, acute depletion of Swp1, also a binding partner
of Wbp1, using an auxin-based degradation system (Morawska
and Ulrich, 2013; Nishimura et al., 2009), resulted in the reduc-
tion of the half-life of the wild-type (WT) Wbp1 protein. Again,
Wbp1 degradation was inhibited in Asi mutant cells (Figure 1F).
These data indicate that unassembled subunits of protein
complexes are targeted for degradation by the Asi complex at
the INM.
We showed that under conditions of compromised assembly,
Asi complex mutations lead to higher steady-state levels of pro-
tein complex subunits. However, whether these subunits would
be competent for assembly and give rise to functional com-
plexes was not clear. Thus, we tested whether Asi mutations
could rescue the growth of ts alleles in OST and GPI-T com-
plexes. The deletion of Asi components rescued the growth of
both OST (wbp1-1, wbp1-2) and GPI-T (gpi8-ts and gpi16-ts)
mutant alleles at the restrictive temperature, indicating that
they gave rise to functional complexes (Figures 1G and S1D).
The growth improvements were specific for the Asi complex110 Molecular Cell 77, 108–119, January 2, 2020mutations and were not observed in the mutants of other
ERAD branches, including Hrd1 and Doa10. Thus, orphan sub-
units targeted by the Asi complex at the INM are folded and
competent to assemble functional complexes. Furthermore,
our data suggest that complex assembly in bulk ER membranes
is facilitated by restricting quality control of the unassembled
subunits to the INM.
Erg11 TMD Is Sufficient for Its Degradation by Asi
To further investigate the mechanisms by which the Asi com-
plex recognizes its substrates, we focused on the lone protein
Erg11, a constitutive and robust Asi substrate (Foresti et al.,
2014; Khmelinskii et al., 2014). Erg11 is anchored at the ER
through a single N-terminal TMD, while the extended cyto-
plasmic C terminus consists of a cytochrome p450 domain
that is essential for ergosterol biosynthesis (Figure 2A) (Monk
et al., 2014).
To identify the minimal region of Erg11 involved in Asi-depen-
dent degradation, we used truncation analysis. A small N-termi-
nal region encompassing an ER luminal amphipathic helix
(residues 6–23) followed by the TMD ahelix (27–51) was suffi-
cient for Asi-dependent degradation. Like full-length Erg11
(Foresti et al., 2014), derivatives including only the first 56
or 68 amino acids followed by a hemagglutinin (HA) epitope,
hereafter called TM56 and TM68 (Figure S2A), still associate
with the ER membrane (Figure S2B). TM56 and TM68 were
quickly degraded in WT cells as well as in hrd1D and doa10D
ERAD mutants. In contrast, degradation of TM56 and TM68
was severely delayed in cells lacking any of the Asi complex
components Asi1, Asi2, or Asi3 (Figures 2B and S2C). We
previously showed that the ubiquitin-conjugating enzymes
Ubc4 and Ubc7 assist the Asi complex in substrate degrada-
tion (Foresti et al., 2014). Similarly, we found that while individ-
ual mutations in Ubc4 and Ubc7 delayed the turnover of
truncated Erg11 derivatives, their simultaneous deletion pre-
vented the degradation of both TM56 and TM68 (Figures 2C
and S2D).
Degradation of Asi substrates is restricted to the INM (Foresti
et al., 2014). However, given the extremely short half-lives of
TM56 and TM68 compared to full-length Erg11, we wanted to
confirm that INM localization was a prerequisite for their degra-
dation. To this end, we manipulated TM68 distribution within
the ER by exploiting the conditional dimerization of FRB and
FK506-binding protein (FKBP) domains induced by the small
molecule rapamycin (Haruki et al., 2008; Spencer et al.,
1993). TM68 was fused to the GFP and FRB domain (TM68-
GFP-FRB), a construct that was still degraded in an Asi-depen-
dent manner (Figure S2E). We coexpressed TM68-GFP-FRB
with fusions of FKBP and monomeric cherry fluorescent protein
to either Pil1 (Pil1-FKBP-mCherry), a protein stably associated
with the cell cortex (Gallego et al., 2013; Zio´1kowska et al.,
2011), or Esc1 (Esc1-FKBP-mCherry), a protein stably associ-
ated with the INM (Andrulis et al., 2002). In the absence of
the dimerization-inducing agent rapamycin, TM68-GFP-FRB
was quickly degraded, irrespective of the coexpressed FKBP
fusion. Likewise, in cells expressing the INM localized Esc1-
FKBP-mCherry, the addition of rapamycin did not affect
the turnover of TM68-GFP-FRB (Figure 2E). In contrast, the
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Figure 2. Erg11 TMD Is Sufficient for Its Asi-Mediated ERAD
(A) Structure of full-length Erg11 according to Monk et al. (2014) and predicted orientation in the ER bilayer. Arrowheads indicate residues 56 and 68.
(B) The degradation of plasmid-derived TM68-HA was followed after the inhibition of protein synthesis by CHX in cells with the indicated genotype. Whole-cell
extracts were analyzed by immunoblotting. TM68 was detected with a-HA antibody. Pgk1 was used as loading control and detected with a-Pgk1 antibody.
(C) The degradation of TM68-HA was analyzed as in (B) in cells with the indicated genotype.
(D) Localization of TM68-sfGFP-FRB-HA in the absence or presence of the dimerization agent rapamycin in cells expressing the cortical (Pil1-FKBP-mCherry, left
panel) or INM (Esc1-FKBP-mCherry, right panel) anchors. Scale bar, 2 mm.
(E) The degradation TM68-sfGFP-FRB-HA was analyzed as in (B) in cells expressing cortical (Pil1-FKBP-mCherry) or INM (Esc1-FKBP-mCherry) anchors in the
absence or presence of the dimerization agent rapamycin.addition of rapamycin to cells expressing cortically associated
Pil1-FKBP-mCherry induced the trapping of TM68-GFP-FRB in
the peripheral ER (Figure 2D), resulting in its complete stabiliza-
tion (Figure 2E). Thus, like other Asi substrates, degradation of
TM68-GFP-FRB requires its diffusion to the INM. The fact that
TM68-GFP-FRB was quick and efficiently trapped at the INM or
peripheral ER indicates that it rapidly explores the entire ER
membrane. These data show that the degradation of TM56
and TM68 has the same genetic and spatial requirements of
their full-length counterpart Erg11.
TMDs Act as Asi-Dependent Degrons
To test whether other TMDs also function as Asi degradation sig-
nals, we generated constructs with the TMDs of the ER proteins
Wbp1 and Gpi8 and Gpi16 belonging, respectively, to the OST
and GPI-T complexes described earlier. These constructs also
included anN-terminal signal sequence for ER targeting followed
by a HA epitope tag. In WT cells, these TMDs were unstable and
degraded with varying half-lives (Figures 3A–3C). However, TMD
degradation was strongly delayed by Asi complex mutations,
while mutations in other ERAD complexes had a much weaker
effect (Figures S3A–S3C). These data show that distinct TMDs
encompassing a range of biophysical properties (Figure S3D)
are degraded in an Asi-dependent manner. Thus, it seems that
TMD a helices define a degradation signal for the Asi complex
at the INM.Asi Components Crosslink to TMD Substrates
To investigate interactions of TMDdegronswith the Asi complex,
we used a sensitive in vivo site-specific photocrosslinking
approach (Chin et al., 2003). Using a similar strategy, we previ-
ously characterized the interactions between ERAD luminal sub-
strates and components of the Hrd1 complex (Carvalho et al.,
2010; Stanley et al., 2011). This system exploits an amber codon
suppressor tRNA and amodified tRNA synthetase to introduce a
photoreactive amino acid derivative (benzoyl-phenylalanine
[Bpa]) at sites specified by an amber stop codon. In cells ex-
pressing this system and grown in the presence of Bpa, UV irra-
diation triggers crosslinks of the Bpa-labeled probes to proteins
in close proximity (Chin et al., 2003).
Wegenerated TM56derivativeswith a single photoreactive Bpa
label at various positions (four to five residues apart) throughout
the TMD (Figure 4A). Given the low steady-state levels and short
half-life of TM56 in WT cells (Figure S2C), crosslinking experi-
ments were performed in ubc7D mutants in which TM56 levels
are higher (Figure S2D). Cells expressing the various Bpa-labeled
TM56 derivatives were UV irradiated, crude membrane extracts
were prepared, and TM56 derivatives were immunoisolated and
analyzed by SDS-PAGE followed by immunoblotting (Figure 4A).
Cells expressing unlabeled TM56 or non-irradiated cells showed
only minor unspecific bands. In contrast, UV-dependent cross-
links were observed for several Bpa positions. The pattern of
crosslinks was similar for various positions (for example, 27, 31,Molecular Cell 77, 108–119, January 2, 2020 111
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Figure 3. TMDs Act as Asi-Dependent Degrons
(A) The degradation of HA-Gpi8 TM was analyzed as in Figure 2B. Schematic representation of HA-Gpi8TM is shown (top) with the various modules of the
construct: a signal sequence (SS) followed by a 3xHA tag and the TM domain. The graph (bottom) shows the quantification of at least three independent ex-
periments; error bars represent the standard deviation.
(B) The degradation of HA-Gpi16 TM domain was analyzed as in (A) in WT and asi1D cells.
(C) The degradation of HA-Wbp1 TM domain was analyzed as in (A) in WT and asi1D cells.36, 39) (Figure 4A). The identity of the most prominent UV-depen-
dent crosslinks remains unknown, but these crosslinkswere inde-
pendent of a functional Asi complex (Figure 4B).
To test whether Asi complex components were among the
TM56 crosslinking partners, we used immunoblotting. We found
that both FLAG-Asi1 and Asi2 crosslinked robustly with Bpa
probes at positions 36 and 39 (Figure 4A). Crosslinks were also
observed at neighboring positions (27 and 47) but became
weaker as the Bpa probe was moved away from membrane
equatorial positions. Crosslinks between TM56 and Asi2
required a full Asi complex and were lost in cells lacking Asi1
or Asi3 (Figure 4B). The loss of Asi2 interactions was not due
to changes in its expression level, which in the mutants was
similar to WT cells (Figure S4A). Finally, similar crosslinks be-
tween Asi2 and TM56were observed inWT cells; however, these
were much weaker due to the lower TM56 levels (Figure S4B).
These data show that Asi complex components directly interact
with a substrate’s TMD.
In Vitro Reconstitution of Asi-Mediated ERAD
Previous studies implicated the ERAD complexes in the recogni-
tion, ubiquitination, and retrotranslocation of substrates (Bal-
dridge and Rapoport, 2016; Carvalho et al., 2010; Christianson
et al., 2011; Denic et al., 2006; Gauss et al., 2006; Stein et al.,
2014). To test whether the Asi complex defined the minimal
unit necessary for the recognition, ubiquitination, and retrotrans-
location of its membrane-bound substrates, we developed an
in vitro system recapitulating these ERAD steps. Asi1, Asi2,
and Asi3 were purified as a complex from Saccharomyces
cerevisiae either through a streptavidin-binding peptide tag
fused to Asi2 (SBP-Asi2) or through FLAG tag on Asi3 (FLAG-
Asi3) (Figure S5A). Both fusion proteins were functional (Fig-
ure S5B) (Foresti et al., 2014). In parallel, we recombinantly
expressed and purified the ubiquitin-activating enzyme Uba1,112 Molecular Cell 77, 108–119, January 2, 2020the ubiquitin-conjugating enzymes Ubc4 and Ubc7, and its
activator Cue1, all required for the ubiquitination reaction
(Figure S5C). Recombinantly expressed TM68 fused to the
maltose-binding protein (TM68-MBP) was used as the substrate.
TM68-MBP also included a sortase recognition peptide, which
allowed its fluorescent labeling for easy detection (Figure S5C).
Ubiquitination experiments in the mild detergent decyl maltose
neopentyl glycol (DMNG), which preserved Asi complex integ-
rity, led to very minor TM68-MBP modification, which could be
detected only after the enrichment of ubiquitin conjugates (Fig-
ure S5D). The very low modification of TM68-MBP was not due
to the decreased activity of the purified Asi complex in detergent,
as prominent ubiquitination of Asi components was detected in
the same reactions (data not shown).
We hypothesized that the detergent micelle did not
adequately recapitulate the environment of a phospholipid
bilayer, considering that Asi-substrate interaction occurs within
the membrane. We therefore co-reconstituted the Asi complex
and TM68-MBP into liposomes. Floatation and pull-down ex-
periments confirmed co-reconstitution of the various mem-
brane components (Figures S5E and S6A). In proteoliposomes,
the majority of both TM68-MBP substrate and the Asi complex
adopted a topology with their cytoplasmic domains facing the
outside, as assayed by protease protection (Figure S5F). Pro-
teoliposomes containing Asi complex and TM68-MBP were
incubated with the soluble ubiquitination machinery (Ubi Mix:
Uba1, Ubc4, Ubc7, Cue1, ubiquitin) in either the presence or
the absence of ATP. Reactions were analyzed by SDS-PAGE
and TM68-MBP visualized by fluorescence. TM68-MBP was
readily detected in high-molecular-weight bands strongly sug-
gestive of ubiquitination (Figure 5A). Consistently, the presence
of slow migrating TM68-MBP species required the presence of
ATP and the Asi complex. To confirm that the high-molecular-
weight bands correspond to ubiquitinated TM68-MBP,
AB
Figure 4. Asi Complex Crosslinks to Transmembrane Substrates
(A) ubc7D cells with chromosomally tagged FLAG-Asi1 expressed from the
ADH1 promoter and plasmid-borne TM56 with the photoreactive amino acid
analog benzoyl-phenylalanine (Bpa) at the indicated positions were subjected
to UV irradiation. Non-irradiated cells were used as controls. Solubilized
membranes were subjected to immunoprecipitation with anti-HA antibodies,
and bound proteins were analyzed by immunoblotting with HA, FLAG, and
Asi2 antibodies.
(B) Cells of the indicated genotype and expressing TM56 derivatives with Bpa
at selected positions were analyzed as in (A).ubiquitin conjugates were precipitated under denaturing condi-
tions and eluted material was analyzed as above. Over time, a
fraction of TM68-MBP was ubiquitinated (Figure 5B). TM68-
MBP ubiquitination was dependent on Asi complex ubiquitin
ligase activity, as TM68-MBP was not modified in experiments
carried out with ubiquitination-deficient Asi complex (Fig-
ure 5C). In vitro, the specificity of ubiquitin ligases is often
reduced, resulting in the ubiquitination of any protein in close
proximity. To assess the specificity of the Asi complex
in vitro, we performed ubiquitination reactions with TMDs of
two INM resident proteins that are not degraded by Asi in vivo,
Mps3 and Ubc6. Mps3 was recently shown to be degraded by
the soluble E3 ubiquitin ligase anaphase-promoting complex
(APC)/Cdh1 (Koch et al., 2019), while Ubc6 is a well-estab-
lished substrate of the E3 ligase Doa10 (Swanson et al.,
2001). The TMDs of Mps3 and Ubc6 are much less efficiently
ubiquitinated by the Asi complex than TM68-MBP (Figure S5G).
In the case of Ubc6, Asi-dependent ubiquitination increases at
higher substrate concentrations, while Mps3 modification
remains low, even when it is present at high concentrations
in the proteoliposomes (Figure S5G). Liposome floatationassays show that the differences in ubiquitination do not
result from diminished protein reconstitution efficiency (Fig-
ure S5H). Thus, the Asi complex is necessary and sufficient
for the recognition and ubiquitination of integral membrane
substrates.
In cells, the Asi-mediated ERAD branch depends on the ubiq-
uitin-conjugating enzymes Ubc4 and Ubc7 (Foresti et al., 2014).
To test whether there was a similar dependence in vitro and the
individual contribution of the conjugating enzymes, we per-
formed reactions with only Ubc4 or Ubc7. With only Ubc4,
TM68-MBP was still ubiquitinated, but the conjugates had a
distinct profile, with an increase in monoubiquitinated species
and a reduction in high-molecular-weight conjugates, when
compared to reactions with both Ubc4 and Ubc7 (Figure 5D).
Asi3 was also ubiquitinated in vitro, amodificationmostly depen-
dent on Ubc4 (Figure 5D). Substrate ubiquitination was absent in
reactions containing exclusively Ubc7 (Figure 5D), even if this
enzyme was active, as confirmed by in vitro reactions with the
ubiquitin ligase Hrd1 (data not shown). These results suggest
that Ubc4 initiates the ubiquitination of Asi substrates. In con-
strast, Ubc7 appears unable to initiate substrate ubiquitination
but efficiently extends ubiquitin chains.
Finally, we tested whether ubiquitinated TM68-MBP could be
retrotranslocated and extracted from the proteoliposomes. To
this end, ubiquitination was performed in proteoliposomes im-
mobilized onto streptavidin beads using SBP-Asi2 and substrate
extraction was initiated by the addition of the Cdc48/Npl4/Ufd1
ATPase complex. Extraction of TM68-MBP required its ubiquiti-
nation, the presence of a complete Cdc48 ATPase complex, and
ATP (Figure 5E). Cdc48-dependent extraction appears substrate
specific, as we could not detect the extraction of polyubiquiti-
nated Asi3 molecules (Figure 5E). Only substrate carrying more
than three to four ubiquitin molecules was efficiently extracted
from proteoliposomes, suggesting a ubiquitin-chain size depen-
dence for Cdc48 activity. Considering the effects of Ubc4 and
Ubc7 in Asi-dependent substrate ubiquitination, we tested
whether their concerted activity was necessary for substrate
extraction. Cdc48 was unable to extract substrate molecules
ubiquitinated in the presence of Ubc4 alone, in contrast to reac-
tions containing both Ubc4 and Ubc7 (Figure 5F). These data
suggest that Ubc4 is competent for monoubiquitination of multi-
ple lysine residues but unable to generate polyubiquitin chains,
shown to preferentially bind to the Cdc48 ATPase complex (Bod-
nar and Rapoport, 2017). Our data show that the Asi complex de-
fines the minimal unit required for ERAD of INM substrates.
Asi2 Is a Transmembrane Recognition Factor
Our in vivo crosslinking experiments suggest that the Asi ubiq-
uitin-ligase complex is involved in recognizing its substrates
within the membrane. To directly test whether interactions
with the TMD are a prerequisite for substrate recognition and
ubiquitination, we took advantage of the described in vitro
system. TM68-MBP and the Asi complex were either reconsti-
tuted together in the same proteoliposomes or individually
into different proteoliposomes (Figure 6A). Ubiquitination reac-
tions were performed as before using the individual proteolipo-
somes or by mixing proteoliposomes containing either the Asi




Figure 5. In Vitro Reconstitution of Asi-Mediated ERAD
(A) Proteoliposomes containing fluorescently labeled TM68-MBP alone or together with the Asi complex were incubated with soluble ubiquitination machinery
(Ubi Mix) during the indicated time in the presence or absence of ATP. Samples were resolved by SDS-PAGE and analyzed by fluorescence scanning.
(B) Proteoliposomes containing Asi complex were incubated with Ubi Mix and ATP for the indicated times. Reactions were divided in two, with one part analyzed
by fluorescence scanning (bottom panel; TM68-MBP) and the other subjected to His-ubiquitin affinity purification. Eluted proteins were analyzed by fluorescence
scanning (top panel; UbTM68).
(C) Proteoliposomes containing either WT or RING-deficient Asi complex were incubated with Ubi Mix for 60 min in the presence or absence of ATP. Proteo-
liposomes lacking Asi complex were used as control. Reactions were either analyzed directly by immunoblotting with a-SBP and a-Asi3 antibodies or fluo-
rescence scanning (TM68-MBP) (bottom panels) or subjected to His-ubiquitin affinity purification. Eluted proteins were analyzed by fluorescence scanning (top
panel; UbTM68).
(D) Proteoliposomes containing the Asi complex were incubated with ubiquitin-activating enzyme, ubiquitin, the indicated ubiquitin-conjugating enzymes, and
ATP for 60min. Reactions were analyzed directly by SDS-PAGE (center panels) or subjected to His-ubiquitin affinity purification. Eluted proteins were analyzed by
fluorescence scanning (top panel) or immunoblotting (bottom panel). Line scan fluorescence intensity profiles are graphed at right.
(E) Proteoliposomes containing fluorescently labeled TM68 and the Asi complex were immobilized on streptavidin magnetic beads and subjected to ubiquiti-
nation reactions for 60min. Substrate extraction was initiated by the addition of the indicated Cdc48 ATPase complex components in the presence or absence of
hexokinase/glucose for ATP depletion and incubated for 30 min. Extracted material was recovered by His-ubiquitin affinity purification. Eluted proteins were
analyzed by fluorescence scanning (TM68-MBP) or immunoblotting (FLAG-Asi3).
(F) Proteoliposomes containing fluorescently labeled TM68-MBP and the Asi complex were immobilized on streptavidin magnetic beads and subjected to
ubiquitination with the indicated ubiquitin conjugating enzymes. Substrate extraction reactions were performed as in (E).only if the substrate and the Asi complex were in the same pro-
teoliposome (Figures 6B and S6A), further indicating that sub-
strate recognition, preceding ubiquitination, occurs through
the TMD.
To gain more insight into the mechanism of substrate recogni-
tion, we set out to identify its main interactor(s) within the
Asi complex. To this end, a version of TM68-MBP containing
a single cysteine within its TMD (at position 36) was recombi-
nantly expressed, purified, and co-reconstituted with the Asi
complex into proteoliposomes. Single cysteine TM68(I36C)-
MBP behaved indistinguishably from TM68-MBP (Figure S6B).
To identify TM68(I36C)-MBP binding partners within the mem-
brane, proteoliposomes were treated with the bifunctional114 Molecular Cell 77, 108–119, January 2, 2020sulfhydryl crosslinker 1,4-bismaleimidobutane (BMB). Proteoli-
posomes containing either only TM68-MBP or lacking the Asi
complex were used as controls. After quenching, crosslinking
reactionswere analyzed by SDS-PAGE and immunoblotting. Be-
sides a TM68(I36C)-MBP dimer, we detected a crosslinked
product of 75 kDa. This crosslink was observed exclusively in
samples treated with BMB and only if TM68(I36C)-MBP and
the Asi complex were included (Figure 6C). Considering the mo-
lecular weight of Asi complex components, the 75-kDa band
could correspond to a crosslink between TM68(I36C)-MBP
and SBP-Asi2, which is 37 kDa. This was confirmed by
analyzing the crosslinking reactions with an anti-Asi2 antibody




C Figure 6. Asi2 Is a Transmembrane Recogni-
tion Factor
(A) Schematic representation of the proteolipo-
somes used in (B).
(B) The indicated proteoliposomes were incubated
with Ubi Mix for 60 min in the presence or absence
of ATP. Reactions were either analyzed directly by
immunoblotting (bottom panels) or subjected to
His-ubiquitin affinity purification. Eluted proteins
were analyzed by fluorescence scanning (TM68).
(C) Proteoliposomes containing Asi complex either
with TM68-MBP or a derivative with a cysteine
residue at position 36 (I36C-MBP) were incubated
with the bifunctional cysteine-reactive crosslinker
BMB, as indicated. Reactions were analyzed by
immunoblotting with antibodies against MBP (left
panel) and Asi2 (right panel).
(D) The degradation of Erg11-HA was analyzed as in
Figure 2B. Erg11 and Asi2 were detected with a-HA
and a-Asi2 antibodies, respectively. The graph
shows the quantification of at least three indepen-
dent experiments; error bars represent the standard
deviation.
(E) Proteoliposomes containing either the Asi1/Asi2/
Asi3 complex or the Asi1/Asi3 subcomplex were
incubated with Ubi Mix for 60 min in the presence
or absence of ATP. Proteoliposomes lacking the
Asi complex were used as controls. Reactions
were analyzed directly by immunoblotting (bottom
panels) or subjected to His-ubiquitin affinity
purification. Eluted proteins were analyzed by fluo-
rescence scanning (TM68-MBP). Line scan fluo-
rescence intensity profiles are graphed on the right.
(F) Quantification of TM68 ubiquitination from re-
actions performed as in (E). Three ubiquitination
reactions from independent reconstitutions experi-
ments were quantified; error bars represent the
standard deviation.number of cysteines (only 1 versus 19 in Asi1 and 15 in Asi3),
further supporting the specificity of the crosslink. Moreover,
these data are consistent with the in vivo site-specific photocros-
slinking experiments in which prominent crosslinks between
TM56 and Asi2 were detected (Figure 4). Thus, among Asi com-
plex components, Asi2 is the main interactor with a TMD
substrate.
The single cysteine in Asi2 lies on a predicted TMD proximal to
its C terminus. Our crosslinking data show that this TMD is in
close proximity to substrates, andwewondered whether it would
be necessary for substrate recognition and degradation. To test
this hypothesis, we deleted four amino acids (residues 261–
264, corresponding to Leu, Cys, Leu, and Leu, respectively) to
generate a mutant Asi2 protein, Asi2D4, with a shortened TMD.
In cells, Asi2D4 assembled into the Asi complex (Figure S6C)
and was expressed at near-normal levels (Figures 6D and S6C);
however, Asi2D4was unable to promote the efficient degradationMoleof Asi substrate Erg11, even if overex-
pressed (Figure 6D). This indicates that
Asi2-substrate interactions within the
membrane are required for substrate
recognition and efficient degradation.
Finally, we tested the role of Asi2 in sub-
strate recognition using the in vitro assaydescribed above. Proteoliposomes containing TM68-MBP and
the entire Asi complex or only the Asi1/Asi3 subcomplex were
used in the ubiquitination reactions. In the absence of Asi2, sub-
strate ubiquitination was reduced to 28% (±8%) (Figure 6E). This
was not a consequence of a general decrease in Asi1/Asi3 ubiq-
uitin ligase activity, as Asi3 was comparably ubiquitinated irre-
spective of the presence of Asi2 (Figure 6E; data not shown).
Thus, Asi2-mediated recognition facilitates substrate ubiquitina-
tion and degradation both in vitro and in vivo.
DISCUSSION
Here, we used genetic, biochemical, and in vitro reconstitution
approaches to characterize the mechanism of INM quality con-
trol by the Asi complex. We found an unexpected link between
the INMproteome identity and quality control of the protein com-
plex assembly.cular Cell 77, 108–119, January 2, 2020 115
Figure 7. Working Model for Asi-Mediated
Quality Control of the Protein Complex
Assembly
Schematic representation of biogenesis and quality
control of membrane protein complexes in the ER.
Complex subunits that misfold are degraded by the
Hrd1 or Doa10 ERAD branches in bulk ER mem-
branes (gray). Subunits that fold but fail to assemble
eventually diffuse into the INM (brown), where they
are degraded in Asi-dependent ERAD.Based on our findings, we propose the following stepwise
model for the quality control of the protein complex assembly
(Figure 7). Newly synthesized subunits that misfold are quickly
targeted for degradation by ERAD complexes in the bulk ER,
such as Hrd1 and Doa10 (1). Subunits that fold but do not
assemble immediately can diffuse through the ER membrane.
This provides an opportunity to bind to their partners and for
successful complex assembly (2). Compared to unassembled
subunits, assembled complexes have an increased number of
TMDs and often larger cytoplasmic domains, factors that
hinder their passage through the pore membrane to the INM
(Ungricht and Kutay, 2015). Moreover, assembled complexes
likely interact with cytosolic components, which also
contribute to their retention in the ER membranes exposed
to the cytosol. Subunits that fail to find their partners or are
present in over-stoichiometric amounts will persistently diffuse
through the ER and eventually reach the INM (3), where the
Asi complex promotes their degradation (4). Thus, we postu-
late that in yeast, bulk ER membranes and INM define areas
favoring the assembly and degradation of folded, unassem-
bled complex subunits, respectively. Whether a similar spatial
segregation between complex assembly and quality control
also occurs in mammalian cells should be investigated. In
mammalian cells, the degradation of proteins directly from
the INM by an ERAD-like process was described for a mutant
version of the lamin-B receptor (Tsai et al., 2016), but the
components involved in the degradation have not been
identified.
Our findings are in agreement with earlier studies on the OST
complex assembly in yeast that showed a very minor contribu-
tion of Hrd1 and Doa10 ERAD branches in the degradation of
unassembled subunits and only if these were overexpressed,
a condition that likely favors protein misfolding (Mueller
et al., 2015).
The model proposed here is also consistent with recent pro-
teomics studies on age-dependent protein degradation. These
showed that many subunits of protein complexes display a
biphasic degradation kinetics, being short-lived immediately
after synthesis and prior to assembly, but becoming more sta-
ble as they age and after successful assembly with their part-
ners (McShane et al., 2016).116 Molecular Cell 77, 108–119, January 2, 2020Genetic suppression of ts alleles in Asi
complex mutants argues for a major role
of this ERAD branch in the degradation
of orphan subunits at the INM. While the
analysis focused on a limited number ofcomplexes, our conclusions are further supported by unbiased
large-scale genetic interaction studies (Van Leeuwen et al.,
2016), in which Asi mutants suppress conditional alleles on
the subunits of additional complexes. However, we cannot
exclude that other ERAD branches may contribute to quality
control of the complex assembly. The Doa10 complex also lo-
calizes to the INM and has nuclear substrates such as the sol-
uble transcriptional repressor Mat2a (Deng and Hochstrasser,
2006; Swanson et al., 2001) and the membrane proteins Asi2
(Boban et al., 2014) and Ubc6 (Walter et al., 2001). However,
it is unclear whether the degradation of these substrates de-
pends on their assembly state; in its orphan state, the translo-
con subunit Sbh2 is degraded in a Doa10-dependent manner
(Boban et al., 2014; Habeck et al., 2015). Curiously, Sbh2, but
not its paralog Sbh1, was detected at the INM (Smoyer et al.,
2016), but whether the INM pool of Sbh2 is the one targeted
by Doa10 is unknown.
We showed that Asi2 directly recognizes lone and orphan
proteins. Recognition requires substrate INM localization and
is mediated by Asi2 binding to TMDs. While all of the substrates
analyzed here contain a single TMD, other Asi2 substrates are
multispanning membrane proteins (Foresti et al., 2014; Khmelin-
skii et al., 2014). Thus, Asi2 likely also recognizes TMDs within
multipass proteins. The recognition of substrates based on their
orphan state is common to other factors involved in the quality
control of mislocalized membrane proteins. This is the case for
the outer mitochondrial ATPase Msp1 (Weir et al., 2017),
involved in quality control of mislocalized tail-anchored proteins
(Chen et al., 2014; Okreglak and Walter, 2014), and the retrieval
factor Rer1, which transports unassembled membrane proteins
from the Golgi back to the ER (Sato et al., 2001, 2003). Thus, the
absence of a binding partner may be a general feature used in
the quality control of mislocalized membrane proteins.
The identification of structural features recognized by Asi2 on
TMDswill require analysis of a larger number of substrates. How-
ever, the diverse properties of TMDs tested here (Figure S3) sug-
gest that Asi2 has broad specificity. Nevertheless, among the Asi
substrates identified so far there are no INM resident proteins,
suggesting that additional regulation spares these proteins
from Asi-dependent degradation (Foresti et al., 2014; Khmelin-
skii et al., 2014; Smoyer et al., 2019).
The degradation of certain Asi substrates does not require
Asi2 (Foresti et al., 2014; Khmelinskii et al., 2014). Whether
Asi2-independent substrates are directly recognized by Asi1
and Asi3 or involve additional unknown factors is not clear
yet. However, the existence of multiple substrate recognition
modules within the same ERAD complex is common (Christian-
son et al., 2011; Kanehara et al., 2010).
We showed that degradation of Asi substrates involved the
ubiquitin conjugating enzymes Ubc7 and Ubc4 (Foresti et al.,
2014). In vitroUbc4 and Ubc7 conjugating enzymes are required
for distinct, non-redundant functions in substrate ubiquitination.
Ubc4 is required to conjugate initial ubiquitin molecules on the
substrate, which are subsequently extended into polyubiquitin
chains by Ubc7. A similar priming followed by Ubc7-dependent
extension was observed for Doa10-dependent ubiquitination. In
this case, priming was mediated by the conjugating enzyme
Ubc6 and was particularly important for the ubiquitination of
lysine-poor substrates, as Ubc6 facilitates ubiquitin conjugation
to lysine and hydroxylated residues (Weber et al., 2016).
Our in vitro system faithfully recapitulated Cdc48-dependent
membrane extraction of ubiquitinated substrates. Only sub-
strates ubiquitinated in the presence of Ubc4 and Ubc7 conju-
gating enzymes and having four or more ubiquitins were
extracted by Cdc48. This is in agreement with Cdc48 ubiquitin-
binding preferences (Bodnar and Rapoport, 2017). Asi3 was
also prominently ubiquitinated in vitro, but whether this is
physiological, as in the case of Hrd1 (Baldridge and Rapoport,
2016), or a side reaction of the system is unclear. Ubiquitinated
Asi3 did not appear to be extracted from proteoliposomes.
Whether Cdc48 discriminates substrate and Asi3 based on
different ubiquitin linkages or by some other mechanism should
be clarified. It has been shown that Hrd1 ubiquitin ligase facili-
tates the retrotranslocation and membrane extraction of its sub-
strates (Baldridge and Rapoport, 2016; Carvalho et al., 2010;
Schoebel et al., 2017), but whether other ERAD ligases, such
as Asi, work in a similar fashion should also be the focus of future
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Antibodies
Rat monoclonal anti-HA Roche 11867431001
Mouse monoclonal anti-Pgk1 Invitrogen 459250
Mouse monoclonal anti-Dpm1 Invitrogen A-6429
Mouse monoclonal anti-FLAG M2-Peroxidase (HRP) Sigma-Aldrich A8592
Mouse monoclonal anti-FLAG M2 Sigma-Aldrich F1804
Mouse monoclonal anti-SBP tag, clone 20 Merck MAB10764
Mouse monoclonal anti-MBP New England BioLabs E8032S
Rabbit polyclonal anti-Wbp1 H. Riezman lab N/A
Rabbit polyclonal anti-Gpi8 A. Conzelmann lab N/A
Rabbit polyclonal anti-Asi1 This study N/A
Rabbit polyclonal anti-Asi2 This study N/A
Rabbit polyclonal anti-Asi3 This study N/A
Bacterial and Virus Strains
BL21-CodonPlus (DE3)-RIPL cells 230280 Agilent Technologies
Chemicals, Peptides, and Recombinant Proteins
Cycloheximide C7698 Sigma
3-Indolacetic acid (Auxin) I2886 Sigma
Rapamycin 37094 Sigma
H-p-Bz-Phe-OH (BPA) F2800.0005 Bachem
Cholesterol 700000 Avanti
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) 850457 Avanti
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) 850725 Avanti
1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) 840035 Avanti
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B
sulfonyl) ammonium salt (18:1 Liss Rhod PE)
810150 Avanti
Decyl Maltose Neopentyl Glycol (DMNG) NG322 Anatrace
Glyco-diosgenin (GDN) GDN101 Anatrace
n-Dodecyl-b-D-Maltopyranoside (DDM) D310 Anatrace
IGEPAL CA-630 (NP40) I8896 Sigma
3x FLAG peptide F4799 Sigma
His-ubiquitin U530 Boston Biochem
DyLight 800 Maleimide 46621 Thermo Scientific
Peptide: Gly-Gly-Gly-Cys, counter ion -chloride This study Thermo Scientific
anti-HA magnetic beads 88837 Thermo Scientific
anti-FLAG M2 affinity gel A2220 Sigma
anti-FLAG M2 magnetic beads M8823 Sigma
Dynabeads Protein A 10002D Thermo Fisher
High capacity streptavidin agarose resin 20361 Thermo Scientific
Streptavidin magnetic beads 88817 Thermo Scientific
NiNTA Agarose Beads 88222 Thermo Scientific
Detergent removal spin columns 87777 Thermo Scientific
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S. cerevisiae: Strain background: BY4741 Research Genetics S288C
S. cerevisiae: Strain background: BY4742 Research Genetics S288C
Mat a ura3-52 his3D200 leu2D1 trp1D63 FY251 yPC1507
Mat a ura3D0 his3D1 leu2D0 met15D0 asi1::KANR Foresti et al., 2014 yPC2008
Mat a ura3D0 his3D1 leu2D0 met15D0 asi2::KANR Foresti et al., 2014 yPC2009
Mat a ura3D0 his3D1 leu2D0 met15D0 asi3::KANR Foresti et al., 2014 yPC2010
Mat a ura3D0 his3D1 leu2D0 met15D0 < pPC1230 > This study yPC11635
Mat a ura3D0 his3D1 leu2D0 met15D0 asi1::KANR < pPC1230 > This study yPC11650
Mat a ura3D0 his3D1 leu2D0 met15D0 asi2::KANR < pPC1230 > This study yPC11636
Mat a ura3D0 his3D1 leu2D0 met15D0 asi3::KANR < pPC1230 > This study yPC11651
Mat a his3D1 leu2D0 lys2D0 ura3D0 doa10::His5 < pPC1230 > This study yPC11652
Mat a ura3-52 his3D200 leu2D1 trp1D63 lys2D0 hrd1::HYGB < pPC1230 > This study yPC11653
Mat a his3D1 leu2D0 lys2D0 ura3D0 ubc7::HYGB < pPC1230 > This study yPC11712
Mat a his3D1 leu2D0 lys2D0 ura3D0 ubc4::KANR < pPC1230 > This study yPC11713
Mat ? his3D1 leu2D0 lys2D0 ura3D0 ubc7::HYGB ubc4::KANR < pPC1230 > This study yPC11714
Can1::Ste2pr-Leu2 Fpr1::Ura tor1-1 LYS+ Lyp1:: leu2D0 his3D1 ura3D0 Pil1-(6)-
RFP-(24)-FKBP::NatR < pPC1356 >
This study yPC9650
Can1::Ste2pr-Leu2 Fpr1::Ura tor1-1 LYS+ Lyp1:: leu2D0 his3D1 ura3D0 Esc1-
RFP-(24)-FKBP::NatR < pPC1356 >
This study yPC9651
Mat a ura3D0 his3D1 leu2D0 met15D0 < pPC1302 > This study yPC11667
Mat a ura3D0 his3D1 leu2D0 met15D0 asi1::KANR < pPC1302 > This study yPC11668
Mat a his3D1 leu2D0 met15D0 ura3D0 doa10::KANR < pPC1302 > This study yPC11669
Mat a ura3-52 his3D200 leu2D1 trp1D63 lys2D0 hrd1::HYGB < pPC1302 > This study yPC11670
Mat a ura3D0 his3D1 leu2D0 met15D0 < pPC1313 > This study yPC11671
Mat a ura3D0 his3D1 leu2D0 met15D0 asi1::KANR < pPC1313 > This study yPC11672
Mat a his3D1 leu2D0 met15D0 ura3D0 doa10::KANR < pPC1313 > This study yPC11673
Mat a ura3-52 his3D200 leu2D1 trp1D63 lys2D0 hrd1::HYGB < pPC1313 > This study yPC11674
Mat a ura3D0 his3D1 leu2D0 met15D0 < pPC1301 > This study yPC11663
Mat a ura3D0 his3D1 leu2D0 met15D0 asi1::KANR < pPC1301 > This study yPC11664
Mat a his3D1 leu2D0 met15D0 ura3D0 doa10::KANR < pPC1301 > This study yPC11665
Mat a ura3-52 his3D200 leu2D1 trp1D63 lys2D0 hrd1::HYGB < pPC1301 > This study yPC11666
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::HYGB NATR-ADHp-3xFlag-
Asi1 < pPC1229+ pPC557 >
This study yPC10511
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::HYGB NATR-ADHp-3xFlag-
Asi1 < pPC1450+ pPC557 >
This study yPC10512
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::HYGB NATR-ADHp-3xFlag-
Asi1 < pPC1451+ pPC557 >
This study yPC10513
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::HYGB NATR-ADHp-3xFlag-
Asi1 < pPC1452+ pPC557 >
This study yPC10514
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::HYGB NATR-ADHp-3xFlag-
Asi1 < pPC1453+ pPC557 >
This study yPC10515
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::HYGB NATR-ADHp-3xFlag-
Asi1 < pPC1454+ pPC557 >
This study yPC10516
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Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::HYGB NATR-ADHp-3xFlag-
Asi1 < pPC1455+ pPC557 >
This study yPC10517
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::HYGB NATR-ADHp-3xFlag-
Asi1 < pPC1456+ pPC557 >
This study yPC10518
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::HYGB NATR-ADHp-3xFlag-
Asi1 < pPC1457+ pPC557 >
This study yPC10519
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR < pPC1229+ pPC557 > This study yPC10502
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR < pPC1451+ pPC557 > This study yPC10504
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR < pPC1453+ pPC557 > This study yPC10506
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR < pPC1454+ pPC557 > This study yPC10507
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR < pPC1456+ pPC557 > This study yPC10509
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR asi1::HYGB < pPC1229+
pPC557 >
This study yPC10520
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR asi1::HYGB < pPC1451+
pPC557 >
This study yPC10521
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR asi1::HYGB < pPC1453+
pPC557 >
This study yPC10522
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR asi1::HYGB < pPC1454+
pPC557 >
This study yPC10523
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR asi1::HYGB < pPC1456+
pPC557 >
This study yPC10524
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR asi3::HYGB < pPC1229+
pPC557 >
This study yPC10525
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR asi3::HYGB < pPC1451+
pPC557 >
This study yPC10526
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR asi3::HYGB < pPC1453+
pPC557 >
This study yPC10527
Mat a ura3-52 his3D200 leu2D1 trp1D63 ubc7::KANR asi3::HYGB < pPC1454+
pPC557 >
This study yPC10528
Mat a ura3-52 his3D200 leu2D1 trp1D63 < pPC1229+ pPC557 > This study yPC10493
Mat a ura3-52 his3D200 leu2D1 trp1D63 < pPC1450+ pPC557 > This study yPC10494
Mat a ura3-52 his3D200 leu2D1 trp1D63 < pPC1451+ pPC557 > This study yPC10495
Mat a ura3-52 his3D200 leu2D1 trp1D63 < pPC1452+ pPC557 > This study yPC10496
Mat a ura3-52 his3D200 leu2D1 trp1D63 < pPC1453+ pPC557 > This study yPC10497
Mat a ura3-52 his3D200 leu2D1 trp1D63 < pPC1454+ pPC557 > This study yPC10498
Mat a ura3-52 his3D200 leu2D1 trp1D63 < pPC1455+ pPC557 > This study yPC10499
Mat a ura3-52 his3D200 leu2D1 trp1D63 < pPC1456+ pPC557 > This study yPC10500
Mat a ura3-52 his3D200 leu2D1 trp1D63 < pPC1457+ pPC557 > This study yPC10501
Mat ? ura3D0 his3D1 leu2D0 asi1::NATR asi2::HYGB asi3::KANR doa10::crispr
hrd1::crispr < pPC1585 + pPC1583 + pPC1586 >
This study yPC11563
Mat ? ura3D0 his3D1 leu2D0 asi1::NATR asi2::HYGB asi3::KANR doa10::crispr
hrd1::crispr < pPC1417 + pPC1587
This study yPC11565
Mat ? ura3D0 his3D1 leu2D0 asi1::NATR asi2::HYGB asi3::KANR doa10::crispr
hrd1::crispr < pPC1417 + pPC1583 + pPC1587 >
This study yPC11566
Mat ? ura3D0 his3D1 leu2D0 asi1::NATR asi2::HYGB asi3::KANR doa10::crispr
hrd1::crispr < pPC1417 + pPC1583 + pPC1581 >
This study yPC11567
Mat a ura3D0 his3D1 leu2D0 met15D0 < pPC1082 > Foresti et al., 2014 yPC8632
Mat a ura3D0 his3D1 leu2D0 met15D0 asi2::KANR < pPC1082 > Foresti et al., 2014 yPC8634
Mat a ura3-52 his3D200 leu2D1 trp1D63 Asi2(261-264D)::crispr < pPC1082 > This study yPC11654
Mat a ura3D0 his3D1 leu2D0 met15D0 NATR-ADHp-3xFlag-Asi2 < pPC1082 > This study yPC11655
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Mat a ura3D0 his3D1 leu2D0 met15D0 NATR-ADHp-3xFlag-Asi2 (261-
264D)::crispr < pPC1082 >
This study yPC11656
Mat a ura3D0 his3D1 leu2D0 met15D0 wbp1-2::KANR Li et al., 2011 yPC8032
Mat ? ura3D0 his3D1 leu2D0 met15D0 wbp1-2::KANR asi1::NATR This study yPC8169
Mat ? ura3D0 his3D1 leu2D0 met15D0 wbp1-2::KANR asi2::NATR This study yPC8370
Mat ? ura3D0 his3D1 leu2D0 met15D0 wbp1-2::KANR asi3::NATR This study yPC8372
Mat ? ura3D0 his3D1 leu2D0 met15D0 wbp1-2::KANR doa10::HIS This study yPC8230
Mat ? ura3D0 his3D1 leu2D0 met15D0 wbp1-2::KANR hrd1::HygB This study yPC8233
Mat ? ura3D0 his3D1 leu2D0 met15D0 wbp1-2::KANR ubc7::HYGB This study yPC8227
Mat a ura3D0 his3D1 leu2D0 met15D0 gpi8-ts::KANR Li et al., 2011 yPC8028
Mat ? ura3D0 his3D1 leu2D0 met15D0 gpi8-ts::KANR asi1::NATR This study yPC11719
Mat ? ura3D0 his3D1 leu2D0 met15D0 gpi8-ts::KANR asi2::NATR This study yPC8671
Mat ? ura3D0 his3D1 leu2D0 met15D0 gpi8-ts::KANR asi3::NATR This study yPC8677
Mat ? ura3D0 his3D1 leu2D0 met15D0 gpi8-ts::KANR doa10::HIS This study yPC8674
Mat a ura3D0 his3D1 leu2D0 met15D0 gpi8-ts::KANR hrd1::HYGB This study yPC8655
Mat a ura3D0 his3D1 leu2D0 met15D0 gpi8-ts::KANR ubc7::HYGB This study yPC8657
Mat a ura3D0 his3D1 leu2D0 met15D0 wbp1-1::KANR Li et al., 2011 yPC8027
Mat a ura3D0 his3D1 leu2D0 met15D0 wbp1-1::KANR asi1::NATR This study yPC8605
Mat a ura3D0 his3D1 leu2D0 met15D0 wbp1-1::KANR asi2::NATR This study yPC8664
Mat a ura3D0 his3D1 leu2D0 met15D0 wbp1-1::KANR asi3::NATR This study yPC8666
Mat a ura3D0 his3D1 leu2D0 met15D0 wbp1-1::KANR doa10::HIS This study yPC8668
Mat a ura3D0 his3D1 leu2D0 met15D0 wbp1-1::KANR hrd1::HYGB This study yPC8652
Mat a ura3D0 his3D1 leu2D0 met15D0 wbp1-1::KANR ubc7::HYGB This study yPC8654
Mat a ura3D0 his3D1 leu2D0 met15D0 lys2D0 can1D::LEU2-MFA1pr::His3
gpi16-ts::URA3
Ben-Aroya et al., 2008 yPC9389
Mat ? ura3D0 his3D1 leu2D0 met15D0 lys2D0 gpi16-ts::URA3 asi1::NATR This study yPC9618
Mat ? ura3D0 his3D1 leu2D0 met15D0 lys2D0 gpi16-ts::URA3 asi2::NATR This study yPC9598
Mat ? ura3D0 his3D1 leu2D0 met15D0 lys2D0 gpi16-ts::URA3 asi3::KANR This study yPC9600
Mat ? ura3D0 his3D1 leu2D0 met15D0 lys2D0 gpi16-ts::URA3 doa10::KANR This study yPC9630
Mat ? ura3D0 his3D1 leu2D0 met15D0 lys2D0 gpi16-ts::URA3 hrd1::KANR This study yPC9632
Mat ? ura3D0 his3D1 leu2D0 met15D0 lys2D0 gpi16-ts::URA3 ubc7::HYGB This study yPC9622
Mat a ura3-52 his3D200 leu2D1 trp1D63 URA3-GPDp-AtTIR1-9Myc Swp1-
4AID-3xFlag-HYGB
This study yPC11735
Mat a ura3-52 his3D200 leu2D1 trp1D63 URA3-GPDp-AtTIR1-9Myc Swp1-
4AID-3xFlag-HYGB asi1::NATR
This study yPC11736
Mat a ura3D0 his3D1 leu2D0 met15D0 lys2D0 can1D::LEU2-MFA1pr::His3 ost2-
ts::URA3
This study yPC9391
Mat ? ura3D0 his3D1 leu2D0 met15D0 lys2D0 ost2-ts::URA3 asi1::NATR This study yPC11309
Mat a ura3D0 his3D1 leu2D0 met15D0 stt3-7::KANR Li et al., 2011 yPC11259
Mat ? ura3D0 his3D1 leu2D0 met15D0 stt3-7::KANR asi1::NATR This study yPC11645
Mat a ura3D0 his3D1 leu2D0 met15D0 lys2D0 can1D::LEU2-MFA1pr::His3 ost2-
ts::URA3 OST4-3xFlag-HYGB
This study yPC11308
Mat ? ura3D0 his3D1 leu2D0 met15D0 lys2D0 ost2-ts::URA3 asi1::NATR OST4-
3xFlag-HYGB
This study yPC11310
Mat a ura3D0 his3D1 leu2D0 met15D0 OST4-3xFlag-HYGB This study yPC11661
Mat a ura3D0 his3D1 leu2D0 met15D0 asi1::KANR OST4-3xFlag-HYGB This study yPC11662
Mat a ura3D0 his3D1 leu2D0 met15D0 < pPC1229 > This study yPC11630
Mat a ura3D0 his3D1 leu2D0 met15D0 asi1::KANR < pPC1229 > This study yPC11646
Mat a ura3D0 his3D1 leu2D0 met15D0 asi2::KANR < pPC1229 > This study yPC11631
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Mat a ura3D0 his3D1 leu2D0 met15D0 asi3::KANR < pPC1229 > This study yPC11647
Mat a his3D1 leu2D0 lys2D0 ura3D0 doa10::His5 < pPC1229 > This study yPC11648
Mat a ura3-52 his3D200 leu2D1 trp1D63 lys2D0 hrd1::HYGB < pPC1229 > This study yPC11649
Mat a his3D1 leu2D0 lys2D0 ura3D0 ubc7::HYGB < pPC1229 > This study yPC11715
Mat a his3D1 leu2D0 lys2D0 ura3D0 ubc4::KANR < pPC1229 > This study yPC11716
Mat ? his3D1 leu2D0 lys2D0 ura3D0 ubc7::HYGB ubc4::KANR < pPC1229 > This study yPC11717
Mat a ura3D0 his3D1 leu2D0 met15D0 < pPC1356 > This study yPC9635
Mat a ura3D0 his3D1 leu2D0 met15D0 asi1::KANR < pPC1356 > This study yPC9637
Mat a ura3D0 his3D1 leu2D0 met15D0 SBP-TEV-ASI2:Crispr < pPC1229 > This study yPC11756
Oligonucleotides
Information on oligonucleotides is available upon request
Recombinant DNA
pRS316 - Erg11p-ERG11TM(D70-521)-3xHA This study pPC1230
pRS413-Erg11p-ERG11TM(D68-521)-sfGFP-FRB-HA This study pPC1356
pRS415-Voa1p-SP-3xHA-GPI8TM (376-411) This study pPC1302
pRS415-Voa1p-SP-3xHA-GPI16TM (542-610) This study pPC1313
pRS415-Voa1p-SP-3xHA-WBP1TM(387-430) This study pPC1301
pRS316 - Erg11p-TM(D58-521)-3xHA This study pPC 1229
TyrRS-tRNACUA Chin et al., 2003 pESC-Bpa
pRS316 - Erg11p-ERG11TM F22 amber(TAG)(D58-521)-3xHA This study pPC1450
pRS316 - Erg11p-ERG11TM L27 amber(TAG)(D58-521)-3xHA This study pPC1451
pRS316 - Erg11p-ERG11TM I31 amber(TAG)(D58-521)-3xHA This study pPC1452
pRS316 - Erg11p-ERG11TM I36 amber(TAG)(D58-521)-3xHA This study pPC1453
pRS316 - Erg11p-ERG11TM F39 amber(TAG)(D58-521)-3xHA This study pPC1454
pRS316 - Erg11p-ERG11TM I43 amber(TAG)(D58-521)-3xHA This study pPC1455
pRS316 - Erg11p-ERG11TM L47 amber(TAG)(D58-521)-3xHA This study pPC1456
pRS316 - Erg11p-ERG11TM L51 amber(TAG)(D58-521)-3xHA This study pPC1457
pRS316 - Erg11p-ERG11-3xHA Foresti et al., 2014 pPC1082
pRS423 - GAL1p-ASI1 This study pPC1417
pRS425 -GAL1p-ASI3 This study pPC1581
pRS423 - GAL1p-ASI1 (D562-624) This study pPC1585
pRS425 -GAL1p-ASI3 (D618-676) This study pPC1586
pRS426-GAL1p-SBP-TEV-ASI2 This study pPC1583
pRS425 -GAL1p-3xFLAG-ASI3 This study pPC1587
K27-T5p-HIS14-sumo-ERG11TM(D70-521)-MBP-LPTEGG This study pPC1822
K27-T5p-HIS14-sumo-ERG11TM(D70-521)(I36C)-MBP-LPTEGG This study pPC1823
K27-T5p-HIS14-sumo-MBP-UBC6TM (225-250)-HA-LPTEGG This study pPC1555
K27-T5p-HIS14-sumo-MPS3TM(149-182)-MBP-LPTEGG This study pPC1556
pET30-b-T7p-ASI1(424-616)-6xHIS This study pPC 1260
pET30-b-T7p-ASI2(153-271)-6xHIS This study pPC1234
pET30-b-T7p-ASI3(484-676)-6xHIS This study pPC 1262
K27-T5p-6xHIS-Sumo-UBC4 pPC 1878
pML107-GAPp-ASI2-gRNA1 This study pPC1661
pML107-GAPp-HRD1-gRNA1 This study pPC1695
pML107-GAPp-DOA10-gRNA1 This study pPC1705
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Software and Algorithms
ImageJ NIH https://imagej.net/welcome
Image studio software Li-Cor Li-Cor https://www.licor.com/bio/
image-studio-lite/
GraphPad Prism N/A https://www.graphpad.com/LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for reagents may be directed to and will be fulfilled by the Lead Contact, Pedro Carvalho (pedro.
carvalho@path.ox.ac.uk). All unique/stable reagents generated in this study are available from the Lead Contact without restriction.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Yeast strains used in this study were S. cerevisiae derivatives of BY4741 or FY251. The genotypes of the strains and their mutant
derivatives are listed in the Key Resources Table.
METHOD DETAILS
Yeast strains and Plasmids
The strains used are isogenic either to BY4741 (Mata ura3D0 his3D1 leu2D0met15D0), BY4742 (Mata his3D1 leu2D0 lys2D0 ura3D0)
or FY251 (Mata ura3-52 his3D200 leu2D1 trp1D63) and are listed in the Table S1. Tagging of proteins and individual gene deletions
were performed by standard PCR-based homologous recombination (Longtine et al., 1998) or CRISPR (Laughery et al., 2015). The
Asi2D4 allele lacking residues (261-264) corresponding to amino acids Leucine, Cysteine, Leucine and Leucine, respectively, was
generated by CRISPR-based gene editing as described (Laughery et al., 2015). In brief, a single guide RNA sequence targeting
the desired region of Asi2 was designed using online software (http://wyrickbioinfo2.smb.wsu.edu) and cloned into a pML vector
(Addgene) containing the Cas9 endonuclease from Streptococcus pyogenes using annealed oligos 3323, 3324. Cas9 plasmid along
with a PCR amplified template containing the deletion of AA (261-264) were transformed using standard transformation protocol.
Colonies were screened by PCR and sequencing of genomic DNA. Positive clones were grown in rich media (YPD) for 2-3 days
to allow the loss of Cas9 plasmid. Guide RNAs are listed in the key resource table.
Strains with multiple gene deletions and temperature sensitive alleles were made by crossing haploid cells of opposite mating
types, followed by sporulation and tetrad dissection using standard protocols (Guthrie and Fink, 1991).
Sanger sequencing was used to determine the sequence of the wbp1-2 temperature sensitive allele. Analysis of several reactions
consistently identified mutations leading to two amino acid changes- F249S and S297L- corresponding to residues in the ER luminal
domain.
Plasmids used in this study are listed in the Key Resources Table and Table S1.
ERAD substrate degradation experiments
Cycloheximide (CHX) shutoff chases were essentially performed as described in Foresti et al. (2014). Briefly, yeast cells were grown
either in richmedia or synthetic media with 2%glucose. CHXwas used at 250ug/ml from a stock of 12.5mg/ml. It was added to expo-
nentially growing culture and 1 OD of cells was collected at the indicated time points. For anchor away technique, 10mM rapamycin
was added 1 hour before the addition of CHX. Temperature sensitive mutants were grown at 25C and shifted to the restrictive tem-
perature as indicated in the corresponding figure legend. For auxin-dependent degradation, 0.8mM auxin was added 1 hour before
the addition of CHX. 1 OD of cells were collected at the specified time points and whole cell lysates were prepared as described
(Kushnirov, 2000) and analyzed by immunoblotting. Antibodies used in this study are listed in the key resource table.
Data quantification was performed using Image Studio software (Li-Cor) or ImageJ and graphs were plotted in Prism. Represen-
tative images of three independent experiment are shown.
In vivo site-specific crosslinking
Cells with various genotypes were transformed with two plasmids. One encoding both for a modified tRNA synthetase capable of
charging the unnatural amino acid benzoyl phenylalanine (BPA) on a tRNA as well as amber stop codon suppressor tRNA. The sec-
ond plasmid encoded for TM56-HA with individual amber codons. Cells carrying both plasmids were grown in synthetic minimal me-
dia and diluted overnight into 100ml of the same media. At 0.3-0.4 OD600, BPA was added to a final concentration of 0.3mM (from a
0.2M in 1M NaOH freshly prepared stock). For BPA incorporation, cells were grown for additional 5-6 hours at 25C. Cells were har-
vested by a centrifuge spin for 2 min at 3000 g and resuspended in 1ml of cold water. Half of cells were transferred to a 12 well plateMolecular Cell 77, 108–119.e1–e9, January 2, 2020 e6
and subjected to UV irradiation for 1 hour at 4C using a B-100AP lamp (UVP, CA). The other half of the cells was incubated on ice and
served as non-irradiated control. After UV irradiation, cells were harvested by centrifuge spin for 2 min at 3000 g. Both irradiated and
control cells were lysed in LB buffer (50mM Tris/HCl [pH7.4], 200mM NaCl, 1mM EDTA, 2mM phenylmethylsulfonyl fluoride(PMSF)
and protease inhibitor cocktail) by 5-6 3 1 min cycles of bead beating. Lysates were cleared by a 10 min centrifugation at 600 g.
Cleared lysates were centrifuged at 100000 g (25 min at 4C) to obtain crude membrane fractions. The membrane pellet was resus-
pended in denaturing buffer (50mM Tris/HCl [pH7.4], 1mM EDTA, 1% SDS, 2M urea) and solubilized at 65C for 30-40 min. Unsolu-
bilized material was pelleted by centrifugation (15 min spin at 13000 g). The solubilized material was diluted with LB supplemented
with 1% Nonidet P-40 and incubated overnight with anti-HA beads (Pierce TM). Beads were washed 3 times with LB/1% Nonidet
P-40 and bound proteins eluted with SDS buffer and analyzed by immunoblotting.
Native Immunoprecipitation
Approximately 100OD of cells grown in YPD were harvested by centrifugation at 3000 g and washed with LB buffer (50mM Tris/HCl
[pH7.4], 200mM NaCl, 1mM EDTA, 2mM phenylmethylsulfonyl fluoride(PMSF) and protease inhibitor cocktail). Lysates and crude
membrane fractions were prepared as described above. Detergent extracts were prepared by solubilizing crudemembrane fractions
in LB/1% glyco-diosgenin (GDN) (Generon) or 1% decyl maltose neopentyl glycol (DMNG). Unsolubilized material was cleared by a
15 min spin at 13000 g. The cleared detergent extracts were incubated overnight at 4C with FLAG M2 magnetic beads (Sigma-Al-
drich) or Protein A beads (Thermo) coupled to anti-Asi1 and Anti-Asi2 antibodies. Beads were washed 3 times with LB/1% GDN or
1% DMNG, eluted with SDS buffer and analyzed by immunoblotting. The input corresponds to 10% of the total extract used for IP.
Growth assays
Cells with the relevant genotypes growing on YPDplates were inoculated in 5mL of YPD and grown overnight at 25C to anOD6003.
Six 10-fold serial dilutions were performed in YPD. 3 ml of the dilutions were spotted on YPD agar plates and incubated at the respec-
tive restrictive temperature for 2-3 days.
Expression and purification of the Asi complex from S. cerevisiae
All three Asi proteins were co-expressed and purified essentially as described (Stein et al., 2014). Briefly, cells lacking ASI1, ASI2,
ASI3, HRD1 and DOA10 were transformed with high copy plasmids from the pRS42X series (Mumberg et al., 1994) encoding un-
tagged Asi1 and Asi3 as well as Asi2 fused to a N-terminal SBP (Streptavidin binding peptide) (Keefe et al., 2001) followed by a
TEV protease cleavage site. A codon optimized version of ASI3 was used. In some cases, an N-terminal FLAG-tagged Asi3 version
was used. Cells were inoculated in Synthetic Drop-out media with 2% (w/v) glucose and grown for 24 hr at 30C. Cells were diluted
1:40 in fresh medium and incubated for additional 24 hr. Protein expression was induced by addition of 8% (w/v) galactose in 4x YEP
broth and incubated for 12 hr. Cell pellets (90 g) were harvested by centrifugation and washed with water and buffer A (20mM
HEPES, 2mM magnesium acetate, 150mM potassium chloride). Cells were resuspended in 140ml of buffer A with 1mM PMSF
and 1.5mM of pepstatin A and transferred to a bead beater chamber (BioSpec) containing 150 g glass beads (0.5mM diameter
from BioSpec). Bead beater chamber was assembled with an ice water jacket. Lysis was induced by 40 cycles of 30’’ on/off. Glass
beadswere removed by filtration and lysates cleared by low-speed spinning at 2000xg for 18min. The supernatant was transferred to
Ti45 tubes and crude membranes were prepared by centrifugation (40,000 rpm for 45 min). Membranes were washed twice with
buffer B (20mMHEPES, 2mMMagnesium acetate, 300mM sodium chloride, 200mM sucrose). The membrane pellet was solubilized
for 90 min in 180ml of buffer B supplemented with 1%(w/v) of DMNG, 1mM PMSF, 1.5mMPepstatin A, 200ul 14,3M of b-mercaptoe-
thanol. Non-solubilized material was removed by centrifugation in Ti45 tubes for 30 min at 40000 rpm. 3 mL of High Capacity Strep-
tavidin Agarose resin (Pierce) or FLAG M2 agarose beads (Sigma) was added to detergent solubilized extract and incubated
overnight. After incubation, the material was transferred to 20 mL gravity columns and beads were washed with 25 column volumes
of buffer C (20mM HEPES, 2mMMagnesium acetate, 300mM sodium chloride, 0.3mM DMNG) by gravity flow. Bound proteins were
eluted with buffer C containing 2mMBiotin (or with 0.15 mg/ml 3xFlag-peptide). Elutedmaterial was concentrated using 50kDa cut off
centrifugal filters (Amicon Ultra, Merck) and snap frozen in liquid nitrogen until use.
Preparation of Liposomes
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-
sn-glycero-3-phospho-L-serine (DOPS), cholesterol and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine
B sulfonyl) ammonium salt (18:1 Liss Rhod PE) were obtained from Avanti lipids and dissolved in chloroform. Lipids were mixed
at a percentage of (64.5:20:10:5:0.5). The chloroform was evaporated in a Rotavap until a lipid film was obtained. Lipids were resus-
pended in 1ml of diethylether and 300ul of an aqueous buffer containing 20mM HEPES/KOH (pH 7.4), 50mM potassium chloride,
5mMmagnesium acetate, sonicated for 1 min and the volume adjusted to 2ml with the aqueous buffer. Diethylether was evaporated
for 3-4 hr using a Rotavap. Liposomes were extruded through 400nm size filters (11x) and 100 nm filters (21x).
Reconstitution into proteoliposomes
Freshly prepared liposomes were partially solubilized using 2mM of DMNG for 30 min on ice. Subsequently 2.3mMof the purified ASI
complex, 0.5mMof TM68 or 0.5 mMMps3TM or 0.5 mMUbc6TMwere added and incubated for 1hr on ice. Themixture was applied toe7 Molecular Cell 77, 108–119.e1–e9, January 2, 2020
detergent removal spin columns (Pierce). This step was repeated 2 times and the final proteoliposomes were used for the in vitro
assays.
Ubiquitination Assay
Proteoliposomes were added to the ubiquitination reaction mix containing buffer U (20mM HEPES (pH 7.4), 2mM magnesium ace-
tate, 150mM sodium chloride, 0.5mMTCEP), 0.2mg/ml BSA 0.23 mMUba1p, 2.1 mMUbc4p, 2.3 mMUbc7p, 2.2 mMCue1p, 122.5 mM
His-ubiquitin (Boston Biochem, from yeast), 2.5mM ATP. Reactions were incubated at 30C for 1 hr. Samples were either analyzed
directly by SDS-PAGE and fluorescence scanning using Li-Cor image or subjected to His-Ub pull down to enrich for ubiquitin con-
jugates. In the latter, reactions were solubilized in buffer D (20mM HEPES (pH 7.4), 2mM magnesium acetate, 150mM sodium chlo-
ride, 6M urea, 10mM imidazole, 1%Triton X-100) for 15min at 4C followed by incubation with Ni-NTA agarose beads (Pierce) for 3 hr
at 4C. Beads were washed five times with buffer E (20mM HEPES (pH 7.4), 2mMmagnesium acetate, 150mM sodium chloride, 6M
urea, 20mM imidazole, 1% Triton X-100). Bound ubiquitin conjugates were eluted using SDS buffer supplemented with 500mM Imid-
azole at 65C for 10 min. Samples were analyzed by SDS-PAGE and fluorescence scanning using Li-Cor imager.
Membrane extraction assay
Freshly prepared proteoliposomes containing TM68 and Asi complex were immobilized via SBP-Asi2 using streptavidin magnetic
beads (Pierce) in buffer U (20mM HEPES (pH 7.4), 2mM magnesium acetate, 150mM sodium chloride, 0.5mM TCEP). Bound pro-
teoliposomes were ubiquitinated as described for the ubiquitination assay. The ubiquitination mix was removed and the beads con-
taining ubiquitinated species were incubated for 30 min at 30C with buffer U supplemented with 500mM Cdc48, 500mMUfd1/Npl4
and 2.5mM ATP. The supernatant containing the extracted proteins was collected and subjected to a His-Ub pulldown, elution, and
analysis were performed as described above for the ubiquitination assay.
Nycodenz floatation assay
Proteoliposomes (25ml) were mixed with 25ml of 80% of nycodenz solution in buffer U and overlayed with 50ml of 30% nycodenz, 50ml
of 15% nycodenz and 50ml of buffer U. It was subjected to centrifugation in TLS55 rotor at 55000 rpm for 1 hr at 4C. Fractions were
collected from the top layer, mixed with SDS buffer and analyzed by SDS-PAGE followed by immunoblotting and fluorescence
scanning.
In vitro crosslinking
Reconstituted proteoliposomes were incubated with 6mM of 1,4-bismaleimidobutane (BMB) for 1 hr at RT. Reactions were stopped
by the addition of SDS buffer and analyzed by SDS-PAGE and immunoblotting.
Recombinant protein expression and purification
TM68-MBP was expressed and purified from E. Coli. Plasmids containing N-terminal His14-Sumo-tag followed by TM68, the
maltose binding peptide (MBP) and a sortase recognition sequence (LPTEGG) were transformed into BL21-CodonPlus (DE3)-
RIPL (Agilent Technologies) cells. Cells were grown overnight in LB media containing Kanamycin. Next morning, cells were diluted
into terrific broth with Kanamycin and protein expression was induced by the addition of 0.5mM of IPTG and grown for additional 3 hr
at 30C. Cells were harvested, washed with water and resuspended in buffer 20mM Tris-HCl (pH 8), 500mM NaCl, 20mM imidazole,
pH 8.0, 1mM PMSF. Cells were lysed by passing through the microfluidizer (5x, 10000 psi). The lysate was cleared by centrifugation
at 4000 rpm for 10 min. Cleared lysates were subjected to ultracentrifugation in Ti45 tubes for 45 min at 40,000 rpm to isolate a crude
membrane fraction.Membranes were resuspended in bufferW (50mMTris-HCl (pH 8.0), 500mMNaCl, 30mM imidazole,1mMPMSF)
supplemented with 1% DDM and solubilized for 90 min. Non solubilized material was removed by centrifugation in Ti45 tubes for
30 min at 40000 rpm. 3 mL of Ni-NTA Agarose beads (Thermo) was added to detergent solubilized extract and incubated for 3hr
at 4C. After incubation, thematerial was transferred to a 20ml gravity column and beads werewashed by gravity flowwith 20 column
volumes of buffer W with 1% DDM and 20 column volumes of cleavage buffer (20mM Tris-HCl (pH 8.0), 200mM NaCl, 10mM imid-
azole,) supplemented with 1% DDM.Washed agarose beads were resuspended in 10ml of the cleavage buffer, transferred to a tube
containing 1mM of sumo protease Ulp1 (Frey and Go¨rlich, 2014) and incubated overnight at 4C. Beads were pelleted by centrifuga-
tion at 2000 rpm for 3 min and TM68-MBPwas collected in the supernatant. This step was repeated twice with fresh cleavage buffer.
Supernatant from all the three centrifuge spins were pooled, concentrated using 30kDa cut off centrifugal filters (Amicon Ultra,
Merck). Concentrated protein was loaded on to a Superdex 200 column (GE) equilibrated with buffer (20mM HEPES (pH 7.4),
200mM NaCl, 0.3mM DMNG). Peak fractions were collected and concentrated again. TM68 was labeled with Dy800 dye using sor-
tase as described in Stein et al. (2014). Labeled TM68 was repurified on a Superdex 200 column (GE) equilibrated with buffer (20mM
HEPES (pH 7.4), 200mM NaCl, 0.3mM DMNG), peak fractions were collected and snap frozen until use.
TM68(I36C) was purified as above except that 0.4mM TCEP was added to all the buffers and it was not labeled.
For Mps3TM purification, plasmid containing N-terminal His14-Sumo-tag followed by Mps3TM (residues 149-182), the maltose
binding peptide (MBP) and a sortase recognition sequence (LPTEGG) were transformed into BL21-CodonPlus (DE3)-RIPL (Agilent
Technologies) cells. Purification procedure was same as TM68-MBP.Molecular Cell 77, 108–119.e1–e9, January 2, 2020 e8
For Ubc6TMpurification, plasmid containing N-terminal His14-Sumo-tag followed by themaltose binding peptide (MBP)- Ubc6TM
(residues 225-250) and a sortase recognition sequence (LPTEGG) were transformed into BL21-CodonPlus (DE3)-RIPL (Agilent Tech-
nologies) cells. It was purified as TM68 except that after cell lysis and ultracentrifugation step to isolate a crude membrane fraction,
soluble supernatant fraction was used to purify Ubc6TM with the same buffers without detergent.
Uba1, Ubc7, Cue1, Cdc48, Npl4-Ufd1 were purified as described (Stein et al., 2014). For Ubc4 purification, a plasmid containing
N-terminal His14-Sumo-tag followed by coding sequence of Ubc4 was transformed into BL21-CodonPlus (DE3)-RIPL (Agilent Tech-
nologies) cells. Cells were grown and protein expression induced by IPTG as described above. Cells were harvested, washed with
water and resuspended in buffer 20mM Tris-HCl (pH 8), 500mM NaCl, 30mM imidazole, pH 8.0, 1mM PMSF. Cells were lysed by
passing through themicrofluidizer (2x, 18000 psi). Lysate was cleared by a centrifugation spin at 4000 rpm for 10min. Cleared lysates
were subjected to ultracentrifugation in Ti45 tube for 30 min at 40,000 rpm. 3ml of Ni-NTA Agarose beads (Thermo) was added to the
soluble fraction and incubated for 3 hr at 4C. After incubation, the material was transferred to a 50ml gravity column and beads were
washed with 4 column volumes of buffer W and 4 column volumes of cleavage buffer supplemented with 200mM sucrose by gravity
flow. Sumo protease treatment was carried on as described above for TM68-MBP. Concentrated protein was subjected to dialysis
with buffer (20mM Tris-HCl (pH 8), 100mM NaCl, 1mM EDTA, 1mM DTT, 200mM sucrose) to remove imidazole and snap frozen
until use.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data quantification was performed using Image Studio software (Li-Cor) or ImageJ and graphs were plotted in Prism. Representative
images of at least three independent experiments are shown.
DATA AND CODE AVAILABILITY
Raw data generated in this study and used in the preparation of the figures has been deposited as Mendeley Dataset and is available
at https://data.mendeley.com/datasets/37g4k2zvt9/draft?a=a91d9772-651b-4684-9d08-b7dab6849ecb.e9 Molecular Cell 77, 108–119.e1–e9, January 2, 2020
